Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI. (Q45891402)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

enzyme replacement therapy

27 February 2020

main subject

0 references

author

Chong Ae Kim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Juan Llerena Jr.

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Dafne D G Horovitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Tatiana S P C Magalhães

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Angelina Acosta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Erlane M Ribeiro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Liane R Giuliani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Durval B Palhares

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ana Carolina de Paula

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Marcelo Kerstenestzy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mara A D Pianovski

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Maria Ione F Costa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Francisca C Santos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ana Maria Martins

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Carolina S Aranda

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jordão Correa Neto

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Gervina Brady Moreira Holanda

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Laércio Cardoso

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Carlos A B da Silva

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Renata C F Bonatti

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Bethania F R Ribeiro

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Maria do Carmo S Rodrigues

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

1 reference

5 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

62-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

Mucopolysaccharidosis VI.

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age--a sibling control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Successful management of difficult infusion-associated reactions in a young patient with mucopolysaccharidosis type VI receiving recombinant human arylsulfatase B (galsulfase [Naglazyme])

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Management guidelines for mucopolysaccharidosis VI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Spinal cord compression in young children with type VI mucopolysaccharidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Mutational analysis of 105 mucopolysaccharidosis type VI patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.02.014

10.1016/J.YMGME.2013.02.014

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535281%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference